Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Calbindin ELISA Kit (AC2534)
Cat.#: ASET-1123
Specifications
Description Rat Calbindin ELISA Kit allows for the in vitro quantitative determination of rat Calbindin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1913 Rat Tau ELISA Kit (AC3324) Quantitative inquiry ASET-2082 Human LAMB3 ELISA Kit (AC3493) Quantitative inquiry ASET-2337 Human GLP1 ELISA Kit (AC3748) Quantitative inquiry ASET-1119 Mouse Hes1 ELISA Kit (AC2530) Quantitative inquiry ASET-1578 Mouse PPAR gamma ELISA Kit (AC2989) Quantitative inquiry ASET-1416 Mouse beta Nerve Growth Factor ELISA Kit (AC2827) Quantitative inquiry ASET-2530 Rat Antidiuretic Hormone ELISA Kit (AC3941) Quantitative inquiry ASET-2014 Human APC ELISA Kit (AC3425) Quantitative inquiry ASET-1906 Human LPPR4 ELISA Kit (AC3317) Quantitative inquiry ASET-2126 Human LAMC2 ELISA Kit (AC3537) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket